UW3-26309-67217
2 vaccinations
1 coded response
3 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 840 / UT
- Registered
- 2020-12-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-26
Registered in v-safe
-
2020-12-26
Dose 1 — Moderna
-
2021-01-29
Dose 2 — Moderna
-
2021-04-30
Survey response — 3 months, dose 2MedDRA: Anosmia, Fatigue, Oropharyngeal pain, Pregnancy, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: I had runny nose, sore throat, severe congestion, severe fatigue, loss of smell prior to being diagnosed with covid-19. I found out I was pregnant two weeks after my first vaccination.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-30
- 2022-01-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-26 | Moderna | |
| 2 | 2021-01-29 | Moderna |
Free text
Release 8 — 3 months, dose 2
Symptoms: I had runny nose, sore throat, severe congestion, severe fatigue, loss of smell prior to being diagnosed with covid-19. I found out I was pregnant two weeks after my first vaccination.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release